Leading BioSciences Inc. is a bio-tech R&D product development company. Our product portfolio includes 7 different IP companies which own patents and world-wide exclusive licenses for 16 different bio-tech product lines and treatments each with strong world-wide intellectual property coverage.
All of Leading BioSciences’ products lines are new methods, new delivery systems, new treatments, or new devices, based on existing FDA approved drugs. Leading BioSciences does not focus on new drug development. Our company is focused on developing new products and treatments
The company’s product lines cover over a dozen disease conditions and an addressable market size of approximately $113 Billion. The graphic above shows the various types of disease types/conditions our products are focused on.
